BioScrip Inc Stock Nasdaq
Equities
US09069N1081
Healthcare Facilities & Services
Sales 2024 * | 4.75B 6.47B | Sales 2025 * | 5.17B 7.04B | Capitalization | 5.05B 6.88B |
---|---|---|---|---|---|
Net income 2024 * | 204M 278M | Net income 2025 * | 234M 319M | EV / Sales 2024 * | 1.18 x |
Net Debt 2024 * | 559M 761M | Net Debt 2025 * | 348M 473M | EV / Sales 2025 * | 1.04 x |
P/E ratio 2024 * |
25
x | P/E ratio 2025 * |
21.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.86% |
Latest transcript on BioScrip Inc
Managers | Title | Age | Since |
---|---|---|---|
John Rademacher
CEO | Chief Executive Officer | 57 | 19-08-05 |
Michael Shapiro
DFI | Director of Finance/CFO | 53 | 14-12-31 |
Caroline Budde
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Kraemer
CHM | Chairman | 69 | 19-08-06 |
David Golding
BRD | Director/Board Member | 62 | 15-04-30 |
John Arlotta
BRD | Director/Board Member | 74 | 19-08-06 |
1st Jan change | Capi. | |
---|---|---|
+17.74% | 83.47B | |
-29.66% | 69.72B | |
-3.24% | 26.37B | |
+3.81% | 17.86B | |
-12.16% | 16.83B | |
+2.47% | 15.7B | |
+74.82% | 13.45B | |
+73.52% | 12.81B | |
+0.14% | 12.44B |